Vertex Pharmaceuticals Incorporated Stock Shares Owned By Institutions
VRTX34 Stock | BRL 619.20 14.62 2.42% |
Vertex Pharmaceuticals Incorporated fundamentals help investors to digest information that contributes to Vertex Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Vertex Stock. The fundamental analysis module provides a way to measure Vertex Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vertex Pharmaceuticals stock.
Vertex |
Vertex Pharmaceuticals Incorporated Company Shares Owned By Institutions Analysis
Vertex Pharmaceuticals' Shares Owned by Institutions show the percentage of the outstanding shares of stock issued by a company that is currently owned by other institutions such as asset management firms, hedge funds, or investment banks. Many investors like investing in companies with a large percentage of the firm owned by institutions because they believe that larger firms such as banks, pension funds, and mutual funds, will invest when they think that good things are going to happen.
More About Shares Owned By Institutions | All Equity Analysis
Shares Held by Institutions | = | Funds and Banks | + | Firms |
Since Institution investors conduct a lot of independent research they tend to be more involved and usually more knowledgeable about entities they invest as compared to amateur investors.
Competition |
Based on the latest financial disclosure, 0.0% of Vertex Pharmaceuticals Incorporated are shares owned by institutions. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Biotechnology industry. The shares owned by institutions for all Brazil stocks is 100.0% higher than that of the company.
Did you try this?
Run Companies Directory Now
Companies DirectoryEvaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals |
All Next | Launch Module |
Vertex Fundamentals
Return On Equity | 0.28 | |||
Return On Asset | 0.17 | |||
Profit Margin | 0.37 % | |||
Operating Margin | 0.49 % | |||
Current Valuation | 372.17 B | |||
Shares Outstanding | 1.03 B | |||
Price To Earning | 18.08 X | |||
Price To Book | 6.20 X | |||
Price To Sales | 49.16 X | |||
Revenue | 8.93 B | |||
Gross Profit | 7.55 B | |||
EBITDA | 4.29 B | |||
Net Income | 3.32 B | |||
Cash And Equivalents | 6.71 B | |||
Cash Per Share | 6.46 X | |||
Total Debt | 509.8 M | |||
Debt To Equity | 0.1 % | |||
Current Ratio | 4.61 X | |||
Book Value Per Share | 13.53 X | |||
Cash Flow From Operations | 2.64 B | |||
Earnings Per Share | 17.03 X | |||
Price To Earnings To Growth | 0.42 X | |||
Number Of Employees | 4.8 K | |||
Beta | 0.46 | |||
Market Capitalization | 403.29 B | |||
Total Asset | 18.15 B | |||
Net Asset | 18.15 B |
About Vertex Pharmaceuticals Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Vertex Pharmaceuticals Incorporated's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vertex Pharmaceuticals using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vertex Pharmaceuticals Incorporated based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Vertex Stock
Vertex Pharmaceuticals financial ratios help investors to determine whether Vertex Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Vertex with respect to the benefits of owning Vertex Pharmaceuticals security.